TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2016 Financial Results and Business Update

Go back to TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2016 Financial Results and Business Update

TG Therapeutics (TGTX) Reports Q4 Loss of $0.48/Share

March 10, 2017 7:42 AM EST

TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.48), versus ($0.37) reported last year.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

... More